Journey Medical (DERM) gains 13.3% shareholder in Wasatch Advisors

Rhea-AI Filing Summary

Wasatch Advisors filed Amendment No. 3 to a Schedule 13G reporting beneficial ownership of 2,858,930 shares of Journey Medical Corp common stock, representing 13.3% of the class. The shares are held with sole power to dispose and sole voting power over 2,664,647 shares, with no shared voting or dispositive authority.

Key Figures

Beneficial ownership: 2,858,930 shares Percent of class: 13.3% Sole voting power: 2,664,647 shares +1 more

4 metrics

Beneficial ownership 2,858,930 shares Journey Medical Corp common stock beneficially owned by Wasatch Advisors

Percent of class 13.3% Portion of Journey Medical Corp common stock class held by Wasatch Advisors

Sole voting power 2,664,647 shares Shares of Journey Medical Corp over which Wasatch Advisors has sole power to vote

Sole dispositive power 2,858,930 shares Shares of Journey Medical Corp over which Wasatch Advisors has sole power to dispose

Key Terms

beneficially owned, sole power to vote or to direct the vote, sole power to dispose or to direct the disposition of, percent of class

4 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 2,858,930"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole power to vote or to direct the vote financial

"(i) Sole power to vote or to direct the vote: 2,664,647"

sole power to dispose or to direct the disposition of financial

"(iii) Sole power to dispose or to direct the disposition of: 2,858,930"

percent of class financial

"(b) | Percent of class: 13.3 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/15/2026 - 05:17 PM Accepted by SEC EDGAR 07/15/2026 - 05:16 PM Learn about SEC filing dates

FAQ

What stake in Journey Medical Corp (DERM) does Wasatch Advisors report?

Wasatch Advisors reports beneficial ownership of 2,858,930 shares of Journey Medical Corp common stock, representing 13.3% of the class, according to Amendment No. 3 to its Schedule 13G filing.

How much voting power does Wasatch Advisors have in Journey Medical Corp (DERM)?

Wasatch Advisors has sole voting power over 2,664,647 shares of Journey Medical Corp and no shared voting power, as disclosed in the Schedule 13G/A ownership table.

What dispositive power over Journey Medical (DERM) shares does Wasatch Advisors hold?

Wasatch Advisors holds sole power to dispose of or direct the disposition of 2,858,930 shares of Journey Medical Corp and no shared dispositive power, giving it unilateral control over those shares’ disposition.

What percentage of Journey Medical Corp (DERM) common stock is owned by Wasatch Advisors?

Wasatch Advisors reports owning 13.3% of Journey Medical Corp’s common stock. This percentage is based on 2,858,930 shares beneficially owned, as stated in Item 4 of the Schedule 13G/A.

Who filed the Schedule 13G/A for Journey Medical Corp (DERM) and where is the filer based?

The Schedule 13G/A was filed by Wasatch Advisors, a Delaware-organized entity with its principal business office at 505 Wakara Way, 3rd Floor, Salt Lake City, Utah 84108, as specified in Item 2.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Journey Medical Corp

(Name of Issuer)

COM

(Title of Class of Securities)

48115J109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 48115J109

1

Names of Reporting Persons

Wasatch Advisors LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,664,647.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,858,930.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,858,930.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.3 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Journey Medical Corp
(b)	Address of issuer's principal executive offices: 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
Item 2.
(a)	Name of person filing: Wasatch Advisors LP
(b)	Address or principal business office or, if none, residence: 505 Wakara Way, 3rd Floor, Salt Lake City, 84108, United States
(c)	Citizenship: DELAWARE
(d)	Title of class of securities: COM
(e)	CUSIP No.: 48115J109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,858,930
(b)	Percent of class: 13.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,664,647
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,858,930
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Wasatch Advisors LP

Signature:	Mike Yeates
Name/Title:	CEO
Date:	07/15/2026